SCHEMBL3855063

SCHEMBL3855063

COc1nc2ccc(-c3cn(C(c4ccccc4)(c4ccccc4)c4ccccc4)nc3-c3ccc(F)cc3)cc2n1-c1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 3/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
MAPK1 P28482 2/20 0.38
CYP2C19 P33261 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
GRIA1 P42261 1/20 0.35
CACNG8 Q8WXS5 1/20 0.35
CACNG2 Q9Y698 1/20 0.35
SCN9A Q15858 1/20 0.33
SRC P12931 1/20 0.33
BRAF P15056 1/20 0.33
KDR P35968 1/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
NR3C1 P04150 3/20 0.33
KMT2A Q03164 2/20 0.33
PGR P06401 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847467 0.86 SCN9A (0.35) CYP1A2ALDH1A1HSD17B10CASP1CASP7
SCHEMBL3846760 0.84 PDE7A (0.36) CYP1A2ALDH1A1HSD17B10CASP1CASP7
SCHEMBL3855066 0.83 ALDH1A1 (0.32) CYP1A2ALDH1A1HSD17B10CASP1CASP7
SCHEMBL3848527 0.82 PTGS2 (0.35) CYP1A2ALDH1A1HSD17B10CASP1CASP7
SCHEMBL3852638 0.80 MAPT (0.37) CYP1A2ALDH1A1HSD17B10CASP1CASP7
SCHEMBL5852255 0.78 SRC (0.38) ALDH1A1MAPK1SRCBRAFKDR
SCHEMBL3847623 0.77 CYP1A2 (0.39) CYP1A2ALDH1A1HSD17B10CASP1CASP7
SCHEMBL3855586 0.74 LMNA (0.39) CYP1A2ALDH1A1HSD17B10MAPK1CYP2C19
SCHEMBL3847832 0.72 QPCT (0.45) ALDH1A1GRIA1CA12CA9KDM4E
SCHEMBL3847727 0.72 PIK3CD (0.41) CYP1A2ALDH1A1HSD17B10MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed